Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://sabrinazate405987.ltfblog.com/35070341/tirzepatide-a-promising-new-treatment-for-obesity